1-8 of 8
Montserrat Elena
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Smoldering Multiple Myeloma: Usefulness of Serum Heavy/Light Chain Measurements for the Evaluation of Evolving Pattern

Carlos Fernandez de Larrea, MD PhD, Ignacio Isola, MD, Esther Moga, Maria Teresa Cibeira, MD PhD, Ester Lozano, PhD, Juan I. Arostegui, Montserrat Elena, Natalia Tovar, MD PhD, Jordi Yague, Laura Rosinol, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4514.
https://doi.org/10.1182/blood-2018-99-117385
Published: 2018
Journal Articles

Long-Term Survivors after Stem Cell Transplantation in Multiple Myeloma: Bone Marrow Minimal Residual Disease, PET/CT and Immunological Status

Carlos Fernández de Larrea, Xavier Calvo, Natalia Tovar, Ester Lozano, Xavier Setoain, Manel Juan, Tania Díaz, Laura Rosiñol, Montserrat Elena, Mª Teresa Cibeira, Ignacio Isola, Maria Rozman, Juan I. Aróstegui, Jordi Yagüe, Joan Bladé, MD
Journal: Blood
Blood (2015) 126 (23): 4192.
https://doi.org/10.1182/blood.V126.23.4192.4192
Published: 2015
Journal Articles

Smoldering Multiple Myeloma: Impact of the Evolving Pattern on Early Progression

Carlos Fernández de Larrea, MD PhD, Ignacio Isola, MD, María Teresa Cibeira, MD PhD, Laura Rosiñol, MD PhD, Xavier Calvo, MD, Natalia Tovar, MD, Montserrat Elena, MD, Laura Magnano, MD, Juan I. Aróstegui, MD PhD, María Rozman, MD PhD, Jordi Yagüe, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3363.
https://doi.org/10.1182/blood.V124.21.3363.3363
Published: 2014
Journal Articles

Prognostic Impact Of Serum Heavy/Light Chain Pairs In Patients With MGUS and Smoldering Myeloma: Long-Term Results From a Single Institution

Carlos Fernández de Larrea, MD, PhD, Laura Magnano, MD, Montserrat Elena, MD, María Teresa Cibeira, MD, PhD, Natalia Tovar, MD, Juan I. Aróstegui, MD, PhD, Fabiola Pedrosa, MS, Laura Rosiñol, MD, Xavier Filella, MD, PhD, Jordi Yagüe, MD, PhD, Joan Bladé, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3132.
https://doi.org/10.1182/blood.V122.21.3132.3132
Published: 2013
Journal Articles

Characterization and Prognostic Impact of Oligoclonal Humoral Response in Patients with Multiple Myeloma After Autologous Stem-Cell Transplantation: Long-Term Results From a Single Institution

Natalia Tovar, Carlos Fernández de Larrea, Juan I. Aróstegui, María Teresa Cibeira, Laura Rosiñol, MD, Montserrat Rovira, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade, MD
Journal: Blood
Blood (2012) 120 (21): 3948.
https://doi.org/10.1182/blood.V120.21.3948.3948
Published: 2012
Journal Articles

Oligoclonal Bands In Patients with Multiple Myeloma In Complete Remission After Induction Chemotherapy: Strong Association with the Use of Novel Agents

Carlos Fernández de Larrea, Natalia Tovar, María Teresa Cibeira, Juan I. Aróstegui, Laura Rosiñol, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade
Journal: Blood
Blood (2010) 116 (21): 2945.
https://doi.org/10.1182/blood.V116.21.2945.2945
Published: 2010
Journal Articles

Response: Free light chain assay and stringent complete remission in multiple myeloma: more questions than answers

Carlos Fernández de Larrea, María Teresa Cibeira, Montserrat Elena, Juan Ignacio Arostegui, Laura Rosiñol, Montserrat Rovira, Xavier Filella, Jordi Yagüe, Joan Bladé
Journal: Blood
Blood (2010) 115 (16): 3414–3415.
https://doi.org/10.1182/blood-2010-01-264036
Published: 2010
Journal Articles

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

Brief Report
Carlos Fernández de Larrea, María Teresa Cibeira, Montserrat Elena, Juan Ignacio Arostegui, Laura Rosiñol, Montserrat Rovira, Xavier Filella, Jordi Yagüe, Joan Bladé
Journal: Blood
Blood (2009) 114 (24): 4954–4956.
https://doi.org/10.1182/blood-2009-06-224832
Published: 2009